Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA's New Paragraph IV Data Further Illustrates Generic Competition Problems
Jun 20 2019
•
By
Derrick Gingery
The US FDA is releasing more patent-related information for generic drug sponsors. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Generics
More from Biosimilars & Generics